ERBAX
Price
$19.82
Change
+$0.05 (+0.25%)
Updated
Jul 25 closing price
Net Assets
672.74M
FWGIX
Price
$72.48
Change
+$0.04 (+0.06%)
Updated
Jul 25 closing price
Net Assets
137.34B
Interact to see
Advertisement

ERBAX vs FWGIX

Header iconERBAX vs FWGIX Comparison
Open Charts ERBAX vs FWGIXBanner chart's image
Eaton Vance RBA Equity Strategy Fd Cl A
Price$19.82
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets672.74M
American Funds Capital World Gr&Inc F3
Price$72.48
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets137.34B
ERBAX vs FWGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ERBAX vs. FWGIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERBAX is a Buy and FWGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FWGIX has more cash in the bank: 137B vs. ERBAX (673M). FWGIX pays higher dividends than ERBAX: FWGIX (1.77) vs ERBAX (0.56). ERBAX was incepted earlier than FWGIX: ERBAX (15 years) vs FWGIX (9 years). ERBAX (1.30) is less costly to investors than FWGIX (0.41). ERBAX is a more actively managed with annual turnover of: 35.00 vs. FWGIX (27.00). ERBAX has a lower initial minimum investment than FWGIX: ERBAX (1000) vs FWGIX (1000000). FWGIX annual gain was more profitable for investors over the last year : 14.19 vs. ERBAX (10.02). FWGIX return over 5 years is better than : 53.11 vs. ERBAX (22.64).
ERBAXFWGIXERBAX / FWGIX
Total Expense Ratio1.300.41317%
Annual Report Gross Expense Ratio1.300.41317%
Fund Existence15 years9 years-
Gain YTD9.50315.23762%
Front Load5%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets673M137B0%
Annual Yield % from dividends0.561.7731%
Returns for 1 year10.0214.1971%
Returns for 3 years22.8052.3544%
Returns for 5 years22.6453.1143%
Returns for 10 years39.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMRA2.350.06
+2.62%
Neumora Therapeutics
BPOPM24.99-0.06
-0.24%
Popular
XBP0.93-0.01
-1.06%
XBP Europe Holdings
EYE25.02-0.32
-1.26%
National Vision Holdings
LEGN43.36-0.85
-1.92%
Legend Biotech Corp